Detail of > 94749-08-3
- CAS Number:
- 94749-08-3
- Name:
Salmeterol xinafoate
- Formula:
- C25H37NO4.C11H8O3
- Molecular Structure:

- Synonyms:
- (+-)-4-Hydroxy-alpha1-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol;Serevent (TN);Ultrabeta;Asmerole;Betamican;(+-)-4-Hydroxy-alpha-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-m-xylene-alpha,alpha-diol;1,3-Benzenedimethanol, 4-hydroxy-alpha1-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-, (+-)-;Astmerole;GR 33343 G;Arial;Salmeterol 1-hydroxy-2-naphthoate;Aeromax;(+-)-4-Hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-m-xylene-alpha,alpha-diol 1-hydroxy-2-naphthoate (salt);2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol;Dilamax;
- Molecular Weight:
- 603.74
- Melting Point:
- 137-138 °C
- Boiling Point:
- 603 °C at 760 mmHg
- Flash Point:
- 318.5 °C
- Solubility:
- slightly soluble in water
- Appearance:
- white to off-white solid
- Hazard Symbols:
Xi- Risk Codes:
- 36/37/38
- Safety:
- 22-24/25-36-26Details
Related products
Other Products
- Titanium Dioxide Carbon black Glutathione Adenosine Cable pulling lubricant
- 12236-85-0C.I. Reactive Blue 14
- 72-00-4Phosphoric acid,2,2-dichloroethenyl diethyl ester
- 94749-08-3Salmeterol xinafoate
- 61916-41-4Chromate(3-),bis[4-[2-[4,5-dihydro-3-methyl-5-(oxo-kO)-1-phenyl-1H-pyrazol-4-yl]diazenyl-kN1]-3-(hydroxy-kO)-1-naphthalenesulfonato(3-)]-,sodium (1:3)
- 103-41-32-Propenoicacid, 3-phenyl-, phenylmethyl ester
- 4271-96-9Pyrimidine,1,4,5,6-tetrahydro-1,2-dimethyl-
- 15093-36-4Thiourea,N-(1-methylethyl)-N'-phenyl-
- 55506-37-12-Thiazolamine,5-chloro-, hydrochloride
- 148019-46-91,2,4,5-Benzenetetracarboxylicacid,1,4-bis[2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]-1-[[(2-methyl-1-oxo-2-propen-1-yl)oxy]methyl]ethyl]ester
- 29926-41-82-Acetyl-2-thiazoline
- 281-23-2Adamantane
- 20407-84-52-Dodecenal, (2E)-
- 13510-35-5Indium iodide (InI3)
- 88495-63-0Artesunate
- 67874-71-9Hexanoic acid,2-ethyl-, bismuth(3+) salt (3:1)
Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!
- Supplier Location:
China (Mainland)(11)
India(6)
United States(2)
Canada(1)
- Business Type:
- Importer/Exporter(14)Lab/Research institutions(3)
- Certificates:
- ISO(1) Production License (0)
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- Determination of Residual Organic Solvents in Salmeterol Xinafoate by Capillary Gas Chromatography
- Determination of Residual Organic Solvents in Salmeterol Xinafoate by Capillary Gas Chromatography. Zhu, Wei; Wang, Yan; Huang, Yueqin; Dai, Jian (Shanghai Institute for Drug Control, Shanghai 200233, Peop. Rep. China). Zhongguo Yiyao Gongye Zazhi, 33(5), 237-238 (Chinese) 2002 Zhongguo Yiyao Gongye Zazhi Bianjibu. CODEN: ZYGZEA. ISSN: 1001-8255. DOCUMENT TYPE: Journal CA Section: 64 (Pharmaceutical Analysis) A simple capillary gas chromatog. method for the detn. of residual ethoxyethane, EtOH, iso-PrOH, EtOAc, THF, CHCl3, and toluene in Salmeterol xinafoate was presented. The linearities were fairly good, limit of detection was 0.074-0. 94749-08-3 and 60-29-7 are also in the experiment.63 ng, and recovery was 89.1-102.7% with relative std. deviation of 2.9-5.2%. .
- Effects of salmeterol xinafoate and fluticasone propionate on immunological activation of human cultured mast cells
- All Rights Reserved.Some chemicals with cas registry numbers like 51-45-6 and 94749-08-3 are also used. Effects of salmeterol xinafoate and fluticasone propionate on immunological activation of human cultured mast cells. Akabane, Hirotomo; Murata, Masayuki; Kubota, Masafumi; Takashima, Eiji; Tanaka, Hiroyuki; Inagaki, Naoki; Horiba, Michiaki; Nagai, Hiroichi (Department of Pharmacology, Gifu Pharmaceutical University, Gifu, Japan). Allergology International, 55(4), 387-393 (English) 2006 Japanese Society of Allergology. CODEN: ALINFR. ISSN: 1323-8930. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacology) Background: The clin. efficacy of combination therapy comprising a long acting b2-agonist (LABA) and corticosteroid is widely recognized for the treatment of adult asthma. Here we examine the effect of salmeterol xinafoate (SX) and fluticasone propionate (FP) alone and in combination on the immunol. activation of human cultured mast cells (HCMC) in vitro. Methods: HCMC were passively sensitized with IgE antibody and then activated by challenging with anti-IgE antibody. The effect of drugs on the activation of mast cells was examd. by measuring the amt. of released chem. mediators (histamine, leukotrienes (LT) and prostaglandin D2 (PGD2)) and granulocyte macrophage colony stimulating factor (GM-CSF). Results: The release of each chem. mediator was inhibited by 10-9-10-8M SX but not by 10-10-10-7M FP. The prodn. of GM-CSF was inhibited by a concn. of 10-8M in both drugs and the inhibition was augmented by combined treatment with 10-11M of each drug. Conclusions: The immunol. release of chem. mediators (histamine, LT, PGD2) from HCMC was inhibited by SX but not by FP. SX and FP inhibited the prodn. of GM-CSF by HCMC and both drug showed synergistic inhibition in the prodn. of GM-CSF. .
- About us
- |
- Payment
- |
- Contact us
- |
- Links
- |
- Help Center
- |
- Disclaimer
- |
- Add to favorite
- | SiteMap
- |
- Product SiteMap
- |
- Manufacturers
- |
- Suppliers
©2008 LookChem.com,License:ICP NO.:Zhejiang10014259
[Hangzhou]86-571-85317600,85317603,85317620

